GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioGend Therapeutics Co Ltd (ROCO:6733) » Definitions » Selling and Marketing Expense

BioGend Therapeutics Co (ROCO:6733) Selling and Marketing Expense : NT$88.2 Mil (TTM As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is BioGend Therapeutics Co Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. BioGend Therapeutics Co's Selling and Marketing Expense for the three months ended in Mar. 2025 was NT$22.3 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2025 was NT$88.2 Mil.

BioGend Therapeutics Co Selling and Marketing Expense Historical Data

The historical data trend for BioGend Therapeutics Co's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGend Therapeutics Co Selling and Marketing Expense Chart

BioGend Therapeutics Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only 6.08 12.13 34.09 52.34 80.39

BioGend Therapeutics Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.40 19.82 21.69 24.48 22.26

BioGend Therapeutics Co Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$88.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioGend Therapeutics Co Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of BioGend Therapeutics Co's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

BioGend Therapeutics Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioGend Therapeutics Co Ltd (ROCO:6733) » Definitions » Selling and Marketing Expense
Comparable Companies
ROCO:6864 TPE:1733 ROCO:8279 ROCO:6634 ROCO:6926 ROCO:4911 ROCO:4169 TPE:6885 ROCO:6986 ROCO:7808 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Yuanqu Street, 4th Floor, Number 3-2, Nangang District, Taipei, TWN, 115
Website
https://www.biogend.com.tw
BioGend Therapeutics Co Ltd is a Taiwan-based company involved in the research and development of orthopedic medical equipment and related products and the sale of related products. It is involved in the research and development of innovative cartilage repair technology and products, adipose stem cell extraction technology, and others. Geographically, the company generates a majority of its revenue from Taiwan followed by China and other regions.

BioGend Therapeutics Co Headlines

No Headlines